Pharmafile Logo

Novo Nordisk AS

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Novo Nordisk AS in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Novo Nordisk AS.

Recent articles on PMLiVE featuring Novo Nordisk AS

- PMLiVE
PMi Awards 2026 – the winners and highlights

Avalere Health was the night’s most awarded agency, with Novo Nordisk, Roche and The Urology Foundation topping the client leaderboard

- PMLiVE
Novo Nordisk UK appoints George Godfrey as Senior Director, Medical & Regulatory

Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK

- PMLiVE
LEO Pharma elects Henriette Mersebach to the Board of Directors

Mersebach previously held senior leadership positions at ALK-Abelló and Novo Nordisk

- PMLiVE
ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board

Sanganee and Schindler previously held senior leadership roles at AstraZeneca and Novo Nordisk, respectively

- PMLiVE
Novo Nordisk’s Wegovy approved as UK’s first daily GLP-1 weight loss pill

The tablets will be available as a once-daily treatment, an alternative to weekly injections for adults with obesity, or overweight with a weight-related condition

- PMLiVE
Inventiva appoints Axel-Sven Malkomes as Chief Financial Officer

Malkomes was most recently CFO at CureVac

- PMLiVE
Novo Nordisk elects employee representatives to Board of Directors

The elected employee representatives will join the Board of Directors after the annual general meeting on 26 March 2026

- PMLiVE
CNX Therapeutics appoints Erin Federman as non-executive director

Federman previously held roles at Novo Nordisk and Mylan

- PMLiVE
Novo Nordisk to invest 432m euros to expand manufacturing facility in Ireland

Construction is expected to be completed in phases from the end of 2027 into 2028

- PMLiVE
Novo Nordisk and Vivtex partner in deal worth up to $2.1bn

The companies aim to develop next-generation oral medicines for obesity and diabetes

Data provided by GlobalData

GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.

Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.

To find out more about how our research and insights can help you, please visit  https://www.globaldata.com/who-we-are/why-globaldata/

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links